Past Webinars
April 28, 2026 (Tuesday), 8:30 AM - 9:30 AM, EDT (New York Time)
Anna Erlandsson, Ph. D.
Professor, Department of Public Health and Caring Sciences, Molecular Geriatrics
Uppsala University, Uppsala
Sweden
Title: Astrocytes: a potential target to reduce cell-to-cell spreading in neurodegenerative diseases
February 12, 2026, 12:00 noon - 1:30 PM, EST (New York Time)
Bradley Hyman, M.D., Ph.D.
Professor of Neurology, Harvard Medical School,
Boston, MA
Alzheimer's Unit Director,
Institute for Neurodegenerative Disease,
Massachusetts General Hospital, Boston, MA
Director, Massachusetts Alzheimer's Disease Research Center, Boston, MA
https://www.massgeneral.org/neurology/research/hyman-lab
https://www.massgeneral.org/doctors/16822/bradley-hyman
https://brain.harvard.edu/?people=bradley-hyman
Title: Alzheimer's Disease: a CNS specific proteinopathy
January 27, 2026, 12:00 noon - 1:30 PM, EST (New York Time)
Frank M. LaFerla, Ph.D.
Distinguished Professor of Neurobiology and Behavior,
University of California, Irvine, CA
Director, Alzheimer's Disease Research Center,
University of California, Irvine, CA
Co-Director, MODEL-AD,
University of California, Irvine, CA
Dean, School of Biological Sciences,
University of California, Irvine, CA
https://laferlalab.bio.uci.edu/
https://dean.bio.uci.edu/about-frank-laferla/
Title: MODEL-AD: New Insights & Advances
January 20, 2026, 12:00 noon -1:30 PM, EST (New York Time)
Charles Glabe, Ph.D.
Professor of Molecular Biology and Biochemistry,
School of Biological Sciences
University of California, Irvine, CA
https://faculty.uci.edu/profile/?facultyId=2441
https://profiles.icts.uci.edu/charles.glabe
Title: The diversity of naturally occurring antibodies declines dramatically in Alzheimer’s disease